AbbVie Current Ratio 2010-2019 | ABBV

Current and historical current ratio for AbbVie (ABBV) from 2010 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. AbbVie current ratio for the three months ending June 30, 2019 was 0.89.
AbbVie Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $15.10B $16.94B 0.89
2019-03-31 $14.41B $13.90B 1.04
2018-12-31 $16.95B $17.24B 0.98
2018-09-30 $18.47B $15.39B 1.20
2018-06-30 $13.85B $17.22B 0.80
2018-03-31 $20.44B $17.06B 1.20
2017-12-31 $21.22B $16.64B 1.28
2017-09-30 $18.93B $13.03B 1.45
2017-06-30 $16.96B $12.26B 1.38
2017-03-31 $15.55B $8.84B 1.76
2016-12-31 $16.19B $9.78B 1.66
2016-09-30 $16.29B $9.10B 1.79
2016-06-30 $16.79B $9.27B 1.81
2016-03-31 $16.62B $10.66B 1.56
2015-12-31 $16.31B $10.89B 1.50
2015-09-30 $17.91B $8.81B 2.03
2015-06-30 $16.88B $11.26B 1.50
2015-03-31 $15.41B $11.05B 1.39
2014-12-31 $16.08B $11.39B 1.41
2014-09-30 $17.56B $6.64B 2.65
2014-06-30 $17.79B $6.32B 2.82
2014-03-31 $17.33B $6.22B 2.79
2013-12-31 $17.85B $6.88B 2.60
2013-09-30 $16.54B $6.88B 2.41
2013-06-30 $15.66B $6.81B 2.30
2013-03-31 $14.92B $6.77B 2.21
2012-12-31 $15.35B $6.78B 2.27
2012-09-30 $10.93B $5.37B 2.04
2012-06-30 $5.99B $4.84B 1.24
2012-03-31 $6.75B $5.52B 1.22
2011-12-31 $7.35B $5.90B 1.25
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $8.22B $3.76B 2.19
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $108.861B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.602B 15.10
Roche Holding AG (RHHBY) Switzerland $247.573B 0.00
Merck (MRK) United States $215.942B 17.76
Pfizer (PFE) United States $199.726B 11.76
Novartis AG (NVS) Switzerland $198.470B 17.08
Novo Nordisk (NVO) Denmark $121.313B 21.43
AstraZeneca (AZN) United Kingdom $114.344B 22.12
Sanofi (SNY) France $112.561B 13.83
GlaxoSmithKline (GSK) United Kingdom $105.206B 13.22
Eli Lilly (LLY) United States $104.614B 19.52
Bristol-Myers Squibb (BMY) United States $84.422B 11.97
Bayer (BAYRY) Germany $66.771B 9.73
H Lundbeck (HLUYY) Denmark $6.541B 9.44